The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
A former British soldier who served in Afghanistan is one of a 'growing number' of westerners joining Kurds in the fight against Isis.
Growing numbers of people on low incomes are turning to food banks to survive, new research has revealed.
It will be cold and frosty across the north of the UK tonight, with some icy patches in the west.